Gaois

Similar terms:

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

4 results

  1. INDUSTRY|chemistry · SOCIAL QUESTIONS|health|pharmaceutical industry
    eisíontas Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    impurity
    en
    Definition any unwanted chemical that is present in a manufactured product or that develops during formulation or upon ageing of that product Reference "COM-Terminology Coordination, based on: PharmTech.com. 'Evaluating Impurities in Drugs (Part III of III)' (17.2.2023)"
  2. SOCIAL QUESTIONS|health|pharmaceutical industry
    eisíontas a bhaineann le próiseas Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    process-related impurity | process-related impurities
    en
    Definition impurity that is derived from the manufacturing process Reference "European Medicines Agency (EMA). 'ICH Topic Q 6 B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. Step 5. NOTE FOR GUIDANCE ON SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS (CPMP/ICH/365/96)' (21.1.2021)"
  3. SOCIAL QUESTIONS|health|pharmaceutical industry
    eisíontas a bhaineann le táirgí Reference "Rialachán Tarmligthe (AE) 2021/805 lena leasaítear Iarscríbhinn II a ghabhann le Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle, CELEX:32021R0805/GA ;Faomhadh an téarma seo mar chuid de Thionscadal Lex"
    ga
    product-related impurity
    en
    Definition molecular variant of the desired product (e.g. precursors, certain degradation products arising during manufacture and/or storage) which does not have properties comparable to those of the desired product with respect to activity, efficacy, and safety Reference "European Medicines Agency (EMA). 'ICH Topic Q 6 B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. Step 5. NOTE FOR GUIDANCE ON SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS (CPMP/ICH/365/96)' (21.1.2021)"
  4. AGRICULTURE, FORESTRY AND FISHERIES|means of agricultural production|means of agricultural production|plant health product
    eisíontas ábhartha Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Context 'Sainaithníodh an t-eisíontas hiodraisín, ar ábhar tosaigh é, mar eisíontas ábhartha, le linn an mheasúnaithe, ós rud é gur aimsíodh é sna baisceanna plandaí píolótacha ar a ndearnadh athmheasúnú agus sna baisceanna plandaí ó na láithreáin tráchtála.' Reference "Rialachán Cur Chun Feidhme (AE) 2021/459 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 maidir le coinníollacha formheasa na substainte gníomhaí feinpiorasaimín, CELEX:32021R0459/GA"
    relevant impurity
    en
    Definition impurity that is particularly undesirable because of its toxicological, ecotoxicological or environmental properties Reference "COM-Terminology Coordination, based on: Regulation (EU) No 283/2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 concerning the placing of plant protection products on the market"